Brief: Landos Biopharma Announces Research Collaboration Into NLRX1 Pathway In Multiple Sclerosis With Johns Hopkins University School Of Medicine
26/08/2021 12:12
Aug 26 (Reuters) - Landos Biopharma Inc LABP.O :
* LANDOS BIOPHARMA ANNOUNCES RESEARCH COLLABORATION INTO
NLRX1
PATHWAY IN MULTIPLE SCLEROSIS WITH JOHNS HOPKINS UNIVERSITY
SCHOOL OF MEDICINE
Source text for Eikon: ID:nGNX8f4P5j
Further company coverage: LABP.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Landos Biopharma
See all newsLandos Biopharma Inc expected to post a loss of 100 cents a share - Earnings Preview
Deals of the day-Mergers and acquisitions
U.S. STOCKS ON THE MOVE-Super Micro, Micron Technology, Navios Maritime
U.S. STOCKS ON THE MOVE-Landos Biopharma, Foot Locker, US energy sector
Brief: AbbVie To Acquire Landos Biopharma